Evidence map›Paper›PMID 29198028›Full record

ArticleEnvironmental science and pollution research international2018

Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice.

Xinmou Wu, Guojie Xie, Xiaoxiao Xu, Wei Wu, Bin Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Mechanisms of Environmental Contributions to Fatty Liver Disease.Current environmental health reports · 2019
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xinmou WuCollege of Pharmacy, Guangxi Medical University, Nanning 530021, Guangxi, China, No.22 Shuangyong Road, Nanning, Guangxi, China.
Guojie XieDepartment of Gynecology, Guigang City People's Hospital, The Eight Affiliated Hospital of Guangxi Medical University, Guigang, 537100, People's Republic of China.
Xiaoxiao XuGuilin Medical University, Guangxi, Guilin, 541004, People's Republic of China.
Wei WuGuilin Medical University, Guangxi, Guilin, 541004, People's Republic of China.
Bin YangCollege of Pharmacy, Guangxi Medical University, Nanning 530021, Guangxi, China, No.22 Shuangyong Road, Nanning, Guangxi, China. gxmu_yangbin@126.com.
Guangxi Medical University · CNGuilin Medical University · CNGuigang City People's Hospital · CN

Funding

National Natural Science Foundation of Guangxi 2016GXNSFAA380081
6 · The paper itself

Abstract

Perfluorooctanoic acid (PFOA), a kind of manufactured material, is widely accumulated around environmental system and into wildlife, including human beings. Toxicologically, PFOA induces hepatomegaly (liver enlargement) in the dose- and time-dependent manners. However, biological mechanism of hepatotoxicity warrants to be further investigated. In the present study, mature male mice were exposed to dosed PFOA for 21 days before conducting biochemical tests and immunoassays. As results, decreased fast blood glucose and elevated insulin contents were observed in PFOA-dosed mice. In addition, PFOA-dosed mice resulted in increased liver functional enzymes (GPT, GOT) in serum. And lipid contents (TG, lipoproteins) in serum and liver were changed abnormally. As shown in immunohistochemistry, increased insulin- and poly (ADP-ribose) polymerase (PARP)-positive cells were showed in PFOA-exposed pancreatic tissues. Moreover, CD36-positive cells were increased in PFOA-exposed livers, while ApoB-labeled cells were reduced. Further, immunoblot data showed that hepatocellular fibroblast growth factor 21 (FGF21) in PFOA-exposed liver was down-regulated dose-dependently. Taken together, our preliminary findings demonstrated that PFOA-induced hepatocellular lipotoxicity may be linked to impairing lipid-regulated proteins, as well as inducing insulin expression from pancreatic tissue.

Indexed as

AnimalsCaprylatesChemical and Drug Induced Liver InjuryDose-Response Relationship, DrugDown-RegulationEnvironmental PollutantsFibroblast Growth FactorsFluorocarbonsInsulinLipid MetabolismLiverLiver Function TestsMaleMiceMice, Inbred StrainsPancreasCaprylatesEnvironmental Pollutantsfibroblast growth factor 21Fibroblast Growth FactorsFluorocarbonsInsulinperfluorooctanoic acidLipidsLiverMetabolismPancreasPFOA

Identifiers

PMID29198028
OpenAlexW2775592096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.